- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03063320
The Effect of Spice Consumption on Postprandial Vascular Function
September 15, 2023 updated by: Penn State University
The Effect of Chronic Consumption of Popular Spices on Postprandial Vascular Function
A 3-period randomized cross-over, controlled feeding study will be conducted to determine the effect of chronic spice consumption on postprandial vascular function.
Participants will consume three test diets containing different amounts of spice.
Each treatment period will last for 4 weeks.
After each diet period a meal test will be conducted.
Participants will consume a meal with a spice content corresponding to the diet period they have just completed.
Endothelial function will be measured at 2 and 4 hours after meal consumption.
Blood samples will also be taken during the 4 hours after meal consumption for measurement of lipids, immune and inflammatory markers.
Study Overview
Detailed Description
A 3-period randomized cross-over, controlled feeding study will be conducted to determine the effect of chronic spice consumption on postprandial vascular function, lipid levels, immune and inflammatory markers.
Participants will consume three test diets containing different amounts of spice.
Each treatment period will last for 4 weeks.
At baseline and after each diet period a postprandial test will be conducted.
Flow mediated dilation (FMD) will conducted in the fasting state and a catheter will be inserted for blood sampling.
Participants will consume a control test meal containing low spice at baseline and after each diet period the test meal will contain a level of spice that corresponds to the amount of spice consumed during the diet period.
Blood samples will be taken at 30, 60, 120, 180 and 240 minutes after meal consumption, and FMD will be performed at 120 and 240 minutes.
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Penn State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Men and postmenopausal women Overweight or obese (25-35kg/m2) Non-smoking Waist circumference >= 94cm for men and >=80cm for women
At least one other of the following:
- LDL- cholesterol >130mg/dL
- CRP >1mg/L
- Triglycerides >=150mg/dL
- HDL <40mg/dL for men or <50mg/dL for women
- Systolic blood pressure >= 130mmHg or diastolic >= 85mmHg
- Fasting glucose >=100mg/dL
Exclusion Criteria:
- Diabetes (fasting glucose >126mg/dL)
- Hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
- Prescribed anti-hypertensive or glucose lowering drugs
- Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease
- Use of cholesterol/lipid lowering medication or supplementation (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals
- Pregnancy or lactation
- Weight loss of >=10% of body weight within the 6 months prior to enrolling in the study
- Vegetarianism
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Low Spice
The test meal (~1200kcal and 44g fat) will contain ~0.6g of spice blend
|
Test spices include cardamom, coriander, cumin, ginger, paprika, red pepper, turmeric, cinnamon
|
Experimental: Moderate Spice
The test meal (~1200kcal and 44g fat) will contain ~3.7g of spice blend
|
Test spices include cardamom, coriander, cumin, ginger, paprika, red pepper, turmeric, cinnamon
|
Experimental: Culinary Spice
The test meal (~1200kcal and 44g fat) will contain ~7.4g of spice blend
|
Test spices include cardamom, coriander, cumin, ginger, paprika, red pepper, turmeric, cinnamon
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in flow mediated dilation
Time Frame: Change from baseline at 2 hours and 4 hours after meal consumption
|
Endothelial function measured by FMD
|
Change from baseline at 2 hours and 4 hours after meal consumption
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lipid and lipoproteins
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides
|
Change from baseline during the 4 hours after meal consumption
|
Plasma Inflammatory cytokines
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Serum: IL-1β, IL-6, IL-10, IL-12p70, interferon-gamma, monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha, TNF-alpha, vascular endothelial growth factor
|
Change from baseline during the 4 hours after meal consumption
|
Inflammatory cytokines in isolated peripheral blood mononuclear cells
Time Frame: Change from baseline during the 4 hours after meal consumption
|
TNF-alpha, IL-6,NF-κB, I-κB, MAP kinase, COX-2, iNOS from stimulated and unstimulated lipopolysaccharides in peripheral blood mononuclear cells.
Activation status of macrophages.
|
Change from baseline during the 4 hours after meal consumption
|
Glucose
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Plasma glucose
|
Change from baseline during the 4 hours after meal consumption
|
Insulin
Time Frame: Change from baseline during the 4 hours after meal consumption
|
Plasma insulin
|
Change from baseline during the 4 hours after meal consumption
|
Plasma antioxidants
Time Frame: Change from baseline during the 4 hours after meal consumption
|
hydrophilic ORAC, lipophilic ORAC, total ORAC
|
Change from baseline during the 4 hours after meal consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Penny M Kris-Etherton, PhD, Penn State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 25, 2017
Primary Completion (Actual)
February 26, 2020
Study Completion (Actual)
February 26, 2020
Study Registration Dates
First Submitted
February 21, 2017
First Submitted That Met QC Criteria
February 21, 2017
First Posted (Actual)
February 24, 2017
Study Record Updates
Last Update Posted (Actual)
September 18, 2023
Last Update Submitted That Met QC Criteria
September 15, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- PKE Spice PP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Spice blend
-
University of California, Los AngelesCompleted
-
Penn State UniversityMcCormick Science InstituteCompletedPediatric ObesityUnited States
-
University of California, Los AngelesCompletedType II Diabetes MellitusUnited States
-
Clinical Nutrition Research Centre, SingaporeNational University Hospital, SingaporeCompletedCardiometabolic RiskSingapore
-
Penn State UniversityMcCormick Science InstituteCompletedPsychological Stress | CardiovascularUnited States
-
Franklin Health ResearchWithdrawnAnxiety | Autism Spectrum DisorderUnited States
-
Franklin Health ResearchRecruiting
-
University of Colorado, DenverMcCormick Science InstituteCompleted
-
Franklin Health ResearchCompletedMorning Sickness | Pregnancy EarlyUnited States
-
King's College LondonCompleted